Antimicrobial Peptidomimetics for Recurrent Septicemia Infections: In Vitro Study for Immuno Compromised Disease Target

Abstract

The frequency of Bacillus subtilis infection such as pneumonia pan-opthalmitis, visceral abscess or musculoskeletal infection etc. complications following bacteremia, meningitis in children & the infection associated with majority of motor vehicle accidents associated with trauma & gun shoot injury. Antibiotics which appear especially useful in the treatment of Bacillus. infection are clindamycin and vancomycin to which vast majority of strains are susceptible in vitro. Our objective is to test the synthesized peptidomimetics with the efforts mainly directed towards the identification of antibacterial compounds against recurrent septicemia infection. Six peptidomimetics namely G-A-L-D (C₆₀-soot Glu-ala-leu-Asp), D-P-F (C₆₀-soot Asp-pro-Phe), I-R (C₆₀-soot Ile-Arg), L-R (C₆₀-soot leu-Arg), E-R (C₆₀-soot Glu-Arg), D-E (C₆₀-soot Asp-Glu), the column eluted compounds were tested for disc diffusion using gram positive Bacillus Subtilis strains at different concentrations predicted by pH and inhibitory concentrations. I-R (C₆₀-soot Ile-Arg), & D-E (C₆₀-soot Asp-Glu) was found to be very effective along with 5 compounds against Bacillus Subtilis strain tested. Maximum activity 100 µg/ml for synthesized peptidomimetics with the corresponding zonal inhibition diameter (11 mm; 11 mm; 14 mm; 11 mm; 11 mm; 14 mm) against Bacillus subtilis strain. This is the first evidence based report that proves I-R (C₆₀-soot Ile-Arg) & D-E (C₆₀-soot Asp-Glu) has shown antibacterial action against gram positive strains of Bacillus Subtilis against recurrent septicemia infection

Key words

bacillus subtilis - antibacterial drug - drug research & Infectious disease

• References

• 1 Marco O, Gianni P. Recurrent Septicemia in an immunocompromised patient due to probiotic strains of bacillus subtilis . Journal of Clinical Microbiology 1998; 36: 325-326
• 2 Alebouyeh A, Gooran Orimi P. et al. Fatal sepsis by Bacillus circulans in an immunocompromised patient. Iran J Microbiol 2011; 3: 156-158
• 3 Ball SC, Sepkowitz K. Infection due to Bacillus cereus in an injection drug user with AIDS: Bacteremia without morbidity. Clin Infect Dis 1994; 19: 216-217
• 4 Arnaout MK, Tamburro RF, Bodner SM. et al. Bacillus cereus causing fulminant sepsis and hemolysis in two patients with acute leukemia. J Pediat Hematol Oncol 1999; 21: 431
• 5 Swayne R, Rampling A, Newsom SW. Intraventricular vancomycin for treatment of shunt associated ventriculitis. J Antimicrob Chemother. 1987; 19: 249-253
• 6 Wong MT, Dolan MJ. Significant infections due to Bacillus species following abrasions associated with motor vehicle-related trauma. Clin Infect Dis 1992; 15: 855-857
• 7 Morgan BS, Larson B, Peyman GA. et al. Toxicity of antibiotic combinations for vitrectomy infusion fluid. Ophthalmic Surg 1979; 10: 74-77
• 8 Krause A, Freeman R, Sisson PR. et al. Infection with Bacillus cereus after close-range gunshot injuries. J Trauma 1996; 41: 546-548
• 9 Bauer AW, Kirby WMM, Sherries JC. et al. Antibiotic susceptibility testing by standardized single disc method. AM J din pathol 1996; 45: 493-496
• 10 Hossain SM, Esmin S, Islam SM. et al. Novel thiocynatato complexex with potent cytotoxic and antimicrobial properties. J pharm pharmacol 2004; 1519-1520
• 11 Reiner R. detection of antibiotic activity in: Antibiotics an introduction. Switzerland: Roche Scientific Services; 1982: 21-25